Trial · NCT07900607
The Mass Balance Recovery, Metabolite Profile and Metabolite Identification of [14C]OD-001 in Healthy Male Participants
NCT07900607, Phase 1, Recruiting, Odyssey Therapeutics, Inc.
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. The Mass Balance Recovery, Metabolite Profile and Metabolite Identification of [14C]OD-001 in Healthy Male Participants. Trials, record NCT07900607. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07900607
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- The Mass Balance Recovery, Metabolite Profile and Metabolite Identification of [14C]OD-001 in Healthy Male Participants
- NCT number
- NCT07900607
- Status
- Recruiting
- Phases
- Phase 1
- Enrollment
- 8 participants, estimated
- Lead sponsor
- Odyssey Therapeutics, Inc.
- Conditions
- Health Volunteers
- Interventions
- [14C]OD-001
- First posted
- 2026-10-28
- Last updated
- 2026-11-05
Source ClinicalTrials.gov
Registered outcomes16
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Mass balance recovery of total radioactivity in all excreta: CumAe | Day 1 to Day 8 | |
| Primary | Mass balance recovery of total radioactivity in all excreta: Cum%Ae | Day 1 to Day 8 | |
| Primary | Number of OD-001 metabolites at ≥10% of total exposure of [14C]-radiolabel in blood | Day 1 to Day 8 | |
| Primary | Identity of OD-001 metabolites at ≥10% of total exposure of [14C]-radiolabel in blood by LC-MS and NMR | Day 1 to Day 8 | |
| Secondary | Rate of elimination of [14C]OD-001 in excreta by Ae | Day 1 to Day 8 | |
| Secondary | Rate of elimination of [14C]OD-001 in excreta by %Ae | Day 1 to Day 8 | |
| Secondary | Secondary Rate of elimination of [14C]OD-001 in excreta by CumAe | Day 1 to Day 8 | |
| Secondary | Rate of elimination of [14C]OD-001 in excreta by Cum%Ae by interval | Day 1 to Day 8 | |
| Secondary | Incidence of treatment-emergent adverse events | Day 1 to Day 8 | |
| Secondary | Percentage of [14C] total radioactivity OD-001 metabolites in excreta | Day 1 to Day 8 |
1 to 10 of 16Source ClinicalTrials.gov
See all 16 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07900607
GET https://conductscience.org/api/trials/v1/NCT07900607/registered